🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Egypt / NCT06439927
Recruiting Not applicable

New Method to Close Nasal Septal Perforation

NCT06439927 · tracked via the Priya Life Science Egypt tracker
Phase
Not applicable
Started
2024-08-01
Last updated
2024-11-05

Condition(s) studied

Nasal Perforated Septum

Investigational drug(s) / intervention(s)

Polycaprolactone nasal mesh

Polycaprolactone nasal mesh: a 3-dimensional fabricated Polycaprolactone nasal mesh

Study summary

The goal of this clinical trial is to investigate if a 3-dimensional fabricated nasal mesh works to close nasal septal perforations. Under general anesthesia, during nasal septal perforation repair surgery, the investigator will place the mesh between the elevated mucoperichondrial flaps opposite the site of the perforation and confirm its original position at both sides under nasal endoscope. Endoscopic examination for septal mucosa status will be done monthly for a three months follow up period.

Eligibility

Sex
ALL
Min age
18 Years
Max age
58 Years
Healthy volunteers
No
Inclusion Criteria: * Patients undergoing nasal septal perforation repair surgery. Exclusion Criteria: * Patients with known allergy to polycaprolactone. * Pregnancy or lactation.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Faculty of Medicine, Helwan University Cairo Egypt Recruiting

More Helwan University trials in Egypt

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06439927 on ClinicalTrials.gov ↗ ← All trials in Egypt